Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging

Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging

Tumor-selective contrast agents have the potential to aid in the diagnosis and treatment of cancer using noninvasive imaging modalities such as magnetic resonance imaging (MRI). Such contrast agents can consist of magnetic nanoparticles incorporating functionalities that respond to cues specific to...

Full description

Bibliographic Details
Main Authors: Schuerle, Simone (Author), Furubayashi, Maiko (Author), Soleimany, Ava P. (Author), Gwisai, Tinotenda (Author), Huang, Wei (Author), Voigt, Christopher A. (Author), Bhatia, Sangeeta N (Author)
Other Authors: Harvard University- (Contributor), Massachusetts Institute of Technology. Research Laboratory of Electronics (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Broad Institute of MIT and Harvard (Contributor), Massachusetts Institute of Technology. Synthetic Biology Center (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2020-05-28T21:41:34Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items